KAI 12L | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

9,042 results for “KAI 12L”

AliveCor Receives CE Mark for Portable 12-Lead ECG System with AI-Powered Cardiac Detection

Kailera Therapeutics Secures $600M Series B to Advance Obesity Drug KAI-9531 to Phase 3 Trials

Kailera Therapeutics Launches with $400M to Advance GLP-1 Based Obesity Therapies

Hengrui and Kailera Present Phase 2 Data for Dual GLP-1/GIP Agonist and Oral GLP-1 Therapies at ADA 2025

Kailera and Hengrui Present Promising Ribupatide Data at ADA 2026, Demonstrating Strong Weight Loss Efficacy

Hengrui Pharma's HRS9531 Shows Promising Weight Loss in Phase 2 Obesity Trial

Germany's Merck KGaA to Acquire Bio-Techne in $11.3 Billion Life Sciences Mega-Deal

ANEUVO Secures FDA Clearance for ExaStim Spinal Cord Stimulation System Following $22M Series C

Cirrus Therapeutics Secures $11M to Advance Gene Therapy Targeting Age-Related Cause of Dry AMD

University of Hong Kong to Enhance AI Tool for Cardiovascular Disease Risk Prediction

Page 1 of 219